(4S, 5R) -3- (tert-Butoxycarbonyl) -2,2-dimethyl-4-phenyloxazolidine-5-carboxylic Acid CAS 143527-70-2

Khoom Piav Qhia

Cov Khoom Npe: (4S, 5R) -3- (tert-Butoxycarbonyl) -2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid TSIS TAU: 143527-70-2

Txhais:

3,5-Oxazolidinedicarboxylic acid, 2,2-dimethyl-4-phenyl-, 3- (1,1-dimethylethyl) ester, (4S, 5R) -;

(4S, 5R) -3- (tert-Butoxycarbonyl) -2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid;

(4S, 5R) -3- (tert-Butoxycarbonyl) -2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid;

(4S, 5R) -2,2-Dimethyl-3 - {[(2-methyl-2-propanyl) oxi] carbonyl} -4-phenyl-1,3-oxazolidine-5-carboxylic acid;

(4S, 5R) -3- (tBoc) -2,2-dimethyl-4-phenyloxazolidine-5-carboxylic Acid;

(4S, 5R) -2,2-dimethyl-3 - [(2-methylpropan-2-yl) oxygencarbonyl] -4-phenyl-1,3-oxazolidine-5-carboxylic acid;

Docetaxel lossis Paclitaxel intermediate;

Tshuaj & Lub Cev Lub Cev

Zog: off-dawb semi khoom

Ntsuas: ≥99.0%

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R & D hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: (4s, 5r) -3- (tert-butoxycarbonyl) -2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid cas 143527-70-2, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: (2 R, 3 S) - 3 - t-butoxy-carbonylamino - 2 - hydroxy - 3 - phenylpropinacid CAS 145514-6 {{0 }} - 1
• Tom ntej: Methyl (2R, 3S) -N-tert-butoxycarbonyl-3-phenylisoserinate CAS 124605-42-1